Secreted SOCS Proteins as Vectors of Lung Macrophage to Epithelial Cell Crosstalk
分泌的 SOCS 蛋白作为肺巨噬细胞与上皮细胞串扰的载体
基本信息
- 批准号:9257198
- 负责人:
- 金额:$ 57.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-01 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAlveolarAlveolar MacrophagesAnatomyAnti-Inflammatory AgentsAnti-inflammatoryAntigensApoptosisBiologicalBronchoalveolar Lavage FluidCISH geneCell physiologyCellsCodeColorCommunicable DiseasesCytokine SignalingDevelopmentDistalElementsEncapsulatedEpithelial CellsExtracellular SpaceFamilyFoundationsGasesGene ExpressionGrowth FactorHomeostasisHumanImmuneImmune responseIn VitroInfectionInflammationInflammatoryInflammatory ResponseInjection of therapeutic agentJanus kinaseLaboratoriesLipopolysaccharidesLiposomesLungLung InflammationLung Lavage FluidMaintenanceMembranePhenotypePhysiologicalProcessPropertyProteinsPulmonary InflammationRecombinantsRegulationRodentRoleSTAT proteinSchemeSignal TransductionSignaling ProteinSurfaceTestingTherapeuticTissuesToxinTranscriptional ActivationVesicleWorkassaultcigarette smokingcytokineexosomein vitro testingin vivoinsightintercellular communicationmacrophagemembermouse modelnovelnovel therapeutic interventionparacrinepublic health relevanceresponserestraintuptakevector
项目摘要
DESCRIPTION (provided by applicant): In order to preserve homeostasis and normal gas exchange function, the lung must restrain inflammatory responses to the continual assault posed by infections, antigens, and toxins. Host responses in the distal lung are dictated in large part by the cross-talk between alveolar epithelial cells (AECs), which comprise the alveolar surface, and alveolar macrophages (AMs), its resident immune cells. Little is known about mechanisms by which AMs control inflammatory responses of AECs. We have recently identified a novel form of intercellular communication in which AMs secrete suppressors of cytokine signaling (SOCS) 1 and 3 proteins within membrane-delimited vesicles that can be taken up by AECs to inhibit inflammatory signaling in response to cytokines in vitro and in vivo. AM secretion of SOCS can be "tuned" by certain bioactive molecules, including those elaborated by AECs. Furthermore, cigarette smoking reduces while adenoviral infection increases SOCS levels in lung lavage fluid, indicating that dysregulation of SOCS secretion is associated with the known alterations in inflammatory responses that characterize these conditions. This proposal seeks to better understand the fundamental mechanisms, biological consequences, and therapeutic ramifications of this novel form of AM-AEC cross-talk. Aim 1 will characterize mechanisms regulating the release of two distinct types of vesicles - microparticles and exosomes - and the secretion of SOCS proteins within them, in response to bioactive molecules as well as AEC-derived factors. Aim 2 will determine the mechanisms controlling uptake of these distinct SOCS-containing vesicles in AECs and the effects of transcellular SOCS delivery on cytokine signaling, inflammatory gene expression, proliferation, and apoptosis in the target cells. Aim 3 will characterize the operative mechanisms for and consequences of dysregulated SOCS secretion in mouse models of acute inflammation induced by cigarette smoking and adenoviral infection. In addition, the effects and therapeutic potential of synthetic liposomal vesicles loaded with recombinant SOCS proteins will be tested in vitro and in vivo. These studies will provide new insights into the regulation of lung inflammation and a foundation for a novel therapeutic approach to its control.
描述(由适用提供):为了保留稳态和正常气体交换功能,肺必须限制对感染,抗原和毒素针对的持续攻击的炎症反应。远端肺中的宿主反应在很大程度上取决于牙槽上皮细胞(AEC)之间的串扰,该细胞(AEC)包含肺泡表面和肺泡巨噬细胞(AMS),即其驻留的免疫电池。关于AMS控制AEC的炎症反应的机制知之甚少。我们最近确定了一种新型的细胞间通信形式,其中AMS秘密补充剂的细胞因子信号传导(SOCS)1和3蛋白质中的膜中蛋白质蛋白可以在体外和IN VIVO中抑制炎症信号,以抑制炎症信号传导,以抑制炎症信号传导。某些生物活性分子(包括由AEC详细说明的分子)可以“调整” SOC的AM分泌。此外,吸烟减少,而腺病毒感染会增加肺灌洗液中的SOC水平,表明SOCS分泌失调与表征这些疾病的炎症反应的已知变化有关。该建议旨在更好地了解这种新型AM-AEC跨话的基本机制,生物学后果和治疗后果。 AIM 1将表征释放两种不同类型的蔬菜(微粒和外泌体)的机制,以及内部SOCS蛋白的分泌,以响应生物活性分子以及AEC衍生的因素。 AIM 2将确定控制这些不同SOC蔬菜在AEC中吸收的机制,以及跨细胞SOC递送对靶细胞中细胞因子信号传导,炎症基因表达,增殖和凋亡的影响。 AIM 3将表征在吸烟和腺病毒感染引起的急性炎症的小鼠模型中,SOCS分泌失调的工作机制和后果。此外,将在体外和体内测试带有重组SOCS蛋白的合成脂质体蔬菜的作用和治疗潜力。这些研究将为调节肺部感染的调节以及一种新型治疗方法的控制提供新的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARC L PETERS-GOLDEN其他文献
MARC L PETERS-GOLDEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARC L PETERS-GOLDEN', 18)}}的其他基金
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis
肺巨噬细胞和成纤维细胞在肺部炎症和纤维化中的新功能
- 批准号:
9900069 - 财政年份:2019
- 资助金额:
$ 57.78万 - 项目类别:
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis
肺巨噬细胞和成纤维细胞在肺部炎症和纤维化中的新功能
- 批准号:
10561635 - 财政年份:2019
- 资助金额:
$ 57.78万 - 项目类别:
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis
肺巨噬细胞和成纤维细胞在肺部炎症和纤维化中的新功能
- 批准号:
10352439 - 财政年份:2019
- 资助金额:
$ 57.78万 - 项目类别:
Novel Functions of Lung Macrophages and Fibroblasts in Pulmonary Inflammation and Fibrosis
肺巨噬细胞和成纤维细胞在肺部炎症和纤维化中的新功能
- 批准号:
10112297 - 财政年份:2019
- 资助金额:
$ 57.78万 - 项目类别:
Secreted SOCS Proteins as Vectors of Lung Macrophage to Epithelial Cell Crosstalk
分泌的 SOCS 蛋白作为肺巨噬细胞与上皮细胞串扰的载体
- 批准号:
9103201 - 财政年份:2015
- 资助金额:
$ 57.78万 - 项目类别:
Secreted SOCS Proteins as Vectors of Lung Macrophage to Epithelial Cell Crosstalk
分泌的 SOCS 蛋白作为肺巨噬细胞与上皮细胞串扰的载体
- 批准号:
8961063 - 财政年份:2015
- 资助金额:
$ 57.78万 - 项目类别:
Control of fibroblast function by prostaglandin E2 and plasminogen activation
前列腺素 E2 和纤溶酶原激活对成纤维细胞功能的控制
- 批准号:
7728502 - 财政年份:2009
- 资助金额:
$ 57.78万 - 项目类别:
Control of fibroblast function by prostaglandin E2 and plasminogen activation
前列腺素 E2 和纤溶酶原激活对成纤维细胞功能的控制
- 批准号:
8294649 - 财政年份:2009
- 资助金额:
$ 57.78万 - 项目类别:
Control of fibroblast function by prostaglandin E2 and plasminogen activation
前列腺素 E2 和纤溶酶原激活对成纤维细胞功能的控制
- 批准号:
7910714 - 财政年份:2009
- 资助金额:
$ 57.78万 - 项目类别:
Control of Fibroblast Function by Prostaglandin E2 and Plasminogen Activation
前列腺素 E2 和纤溶酶原激活对成纤维细胞功能的控制
- 批准号:
8665457 - 财政年份:2009
- 资助金额:
$ 57.78万 - 项目类别:
相似国自然基金
螺旋层状结构的矿化纤维素纳米晶材料的仿生构建及其促牙槽骨组织再生的机制研究
- 批准号:82301152
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
牙周膜细胞通过CXCL1-CXCR2轴调控巨噬细胞极化在正畸牙槽骨改建中的作用研究
- 批准号:82301115
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
长效抑炎修复材料通过诱导巨噬细胞极化促进牙槽骨再生研究
- 批准号:32301129
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Sparcl1调控Myh11+干细胞促进牙槽骨修复再生的机制研究
- 批准号:82370945
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
三维预血管化磷酸钙骨水泥牙槽骨组织工程支架的构建及三维共培养成血管相关机制的研究
- 批准号:82301117
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 57.78万 - 项目类别:
Optimization of a Self-Adjuvanting Particle System for Delivering Respiratory Syncytial Virus Prefusion Protein
用于输送呼吸道合胞病毒预融合蛋白的自我辅助颗粒系统的优化
- 批准号:
10666079 - 财政年份:2023
- 资助金额:
$ 57.78万 - 项目类别:
Investigating the Contribution of the Coxiella Cell Wall to Intracellular Pathogenesis
研究柯克斯体细胞壁对细胞内发病机制的贡献
- 批准号:
10593290 - 财政年份:2023
- 资助金额:
$ 57.78万 - 项目类别:
LOX-1 as a protective countermeasure in response to lung infection
LOX-1 作为应对肺部感染的保护性对策
- 批准号:
10677924 - 财政年份:2023
- 资助金额:
$ 57.78万 - 项目类别:
PET Tracer for Imaging of Lung Inflammation
用于肺部炎症成像的 PET 示踪剂
- 批准号:
10682270 - 财政年份:2023
- 资助金额:
$ 57.78万 - 项目类别: